DioGenix, Fast Forward Partner on NGS-based MDx for MS
November 08, 2012
DioGenix, Fast Forward Partner on NGS-based MDx for MS
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- DioGenix Raises $1.5M for Clinical Trial of MS Test
December 18, 2012 / GenomeWeb Daily News - With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test
January 2, 2013 / Clinical Sequencing News - Asuragen Awarded $6.8M to Commercialize Sequencing-Based Cancer Dx Tests
March 30, 2012 / GenomeWeb Daily News - Lineagen, Fast Forward Team Up on Multiple Sclerosis Biomarkers
December 14, 2011 / GenomeWeb Daily News - GATC Biotech, LifeCodexx Begin Study of Sequencing-based T21 Test
June 28, 2011 / GenomeWeb Daily News